PhRMA refutes FDA study on drug approval

被引：0

|

作者：

Barnett, AA

机构：

来源：

LANCET | 1996年 / 347卷 / 8996期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：254 / 254

页数：1

相关论文

共 50 条

[41] FDA drug approval summary:: Erlotinib (Tarceva®) tablets
Cohen, MH
Johnson, JR
Chen, YF
Sridhara, R
Pazdur, R
ONCOLOGIST, 2005, 10 (07): : 461 - 466
[42] FDA Revokes Approval for Preterm Birth Drug Makena
Harris, Emily
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (17): : 1444 - 1444
[43] FDA LOOKS TO SPEED UP DRUG APPROVAL PROCESS
BOOTH, W
SCIENCE, 1988, 241 (4872) : 1426 - 1426
[44] US - FDA to speed up drug approval process
不详
CHEMISTRY & INDUSTRY, 2003, (01) : 6 - 6
[45] FDA ANNOUNCES 4 INITIATIVES FOR DRUG APPROVAL SYSTEM
不详
CLINICAL PHARMACY, 1992, 11 (07): : 574 - &
[46] FDA UNDER PRESSURE TO EXPEDITE DRUG APPROVAL PROCESS
AGLER, HL
CHEMICAL ENGINEERING PROGRESS, 1995, 91 (08) : 28 - 28
[47] FDA GIVES CONDITIONAL APPROVAL TO CANINE LYMPHOMA DRUG
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 258 (05): : 445 - 445
[48] FDA approval
不详
GERIATRICS, 2001, 56 (11) : 16 - 16
[49] FDA approval
不详
GERIATRICS, 2001, 56 (09) : 16 - 16
[50] FDA approval
不详
GERIATRICS, 2001, 56 (03) : 20 - 20

← 1 2 3 4 5 →